Account
Inquiry
QSC Tirzepatide is a high-purity peptide compound with dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist activity. This pharmaceutical grade material is supplied as a white powder with 99.9% purity, ideal for research applications.
The molecular formula of QSC Tirzepatide is C225H348N48O68, with a molecular weight of 4813. It features a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. This modification contributes to its improved pharmacokinetic profile compared to native peptides.
In clinical studies, QSC Tirzepatide has demonstrated significant potential for metabolic research applications. The compound shows superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists. Research indicates average weight reduction of 15-20.9% in clinical trials at various dosage levels.
Our QSC Tirzepatide is supplied in research quantities with standard packaging of 10mg per vial, 10 vials per box. The product undergoes rigorous quality control testing to ensure batch-to-batch consistency and meets pharmaceutical grade specifications.
As a dual agonist, QSC Tirzepatide represents an innovative approach in metabolic research. The compound mimics natural GIP action while providing enhanced GLP-1 receptor activity. This unique mechanism offers researchers new opportunities to study glucose metabolism and weight regulation pathways.
For laboratory use only. Not for human consumption. Proper storage conditions are essential to maintain peptide stability - store in a cool, dry environment protected from light and moisture.
